Azelby Robert 4
4 · Eliem Therapeutics, Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Azelby Robert
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+500,000→ 500,000 totalExercise: $8.21Exp: 2032-01-26→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/48th of the shares will vest on each monthly anniversary of January 27, 2022.